MIT-MGB Seed Program
The MIT-MGB Seed Program funds interdisciplinary MIT and Mass General Brigham teams to develop innovative technologies addressing major clinical challenges in health and medicine.
Funder: Massachusetts Institute of Technology
Due Dates (Anticipated): June 2027 (Initial proposal submission deadline, projected)
Funding Amounts: Innovator Grants: ~$100k per lab/group for 1 year; Breakthrough Grants: ~$100k–$200k per lab/group per year for 2 years; up to $3M total distributed per grant type annually.
Summary: Funds interdisciplinary MIT–Mass General Brigham research teams to develop innovative technologies transforming clinical practice and health outcomes.
Key Information: Requires joint MIT and Mass General Brigham investigators; funds cannot be distributed to non-MIT collaborators.
Description
The MIT-MGB Seed Program is a collaborative initiative between the Massachusetts Institute of Technology (MIT) and Mass General Brigham (MGB), supported by Analog Devices Inc., designed to catalyze transformative advances in health and medicine. The program funds interdisciplinary research teams from MIT and MGB aiming to develop and translate innovative technologies that address major clinical challenges. Strategic focus areas include mental health, neurodegenerative diseases, AI-enabled diagnostics, and digital health. Emphasis is placed on projects with significant translational potential and the ability to create new research directions by bridging disciplines and fostering novel collaborations.
